NeoStem’s Subsidiary, Progenitor Cell Therapy LLC (“PCT”), Expands Manufacturing Relationship with ImmunoCellular Therapeutics for Dendritic Cell Vaccines
NeoStem Ranked the Number One Fastest Growing Company in the Tri-State Region on Deloitte’s 2013 Technology Fast 500 for the Second Year in a Row
Dr. Robin Smith was interviewed in the November issue of Life Science Leader magazine in which she discussed the Company's future development and its innovative relationship with the Vatican.
On October 29, 2013, NeoStem was profiled on BioTuesdays.com. Dr. Robin Smith spoke about the company and its lead product candidate AMR-001.
On October 25, 2013, Dr. Robin Smith was interviewed by The Huffington Post for its Women in Business feature.
AMR-001: NeoStem's Product Candidate for AMI
Advances in regenerative medicine hold the promise to preserve heart muscle function after a severe heart attack. Watch to learn more about AMR-001 and Amorcyte, a NeoStem subsidiary.